Valle, J. W., & Büchler, M. W. (2014). Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: Ongoing lessons from the ESPAC-3 study. Journal of clinical oncology, 32(6), . https://doi.org/10.1200/JCO.2013.50.7657
Chicago Style (17th ed.) CitationValle, Juan W., and Markus W. Büchler. "Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons from the ESPAC-3 Study." Journal of Clinical Oncology 32, no. 6 (2014). https://doi.org/10.1200/JCO.2013.50.7657.
MLA (9th ed.) CitationValle, Juan W., and Markus W. Büchler. "Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons from the ESPAC-3 Study." Journal of Clinical Oncology, vol. 32, no. 6, 2014, https://doi.org/10.1200/JCO.2013.50.7657.